Clinical trial tests herpes virus-based therapy for neurogenic bladder in people with spinal cord injury

A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann.

Usefulness Questioned for Transplant Center Report Cards

Public report cards for heart transplant centers are under fire for not being meaningful — potentially even misrepresentative of care quality — as a given

April 12, 2024

Why the aspartame in Diet Coke and Coke Zero probably isn’t worth worrying about

This essay was originally published on Gideon Meyerowitz-Katz’s Medium blog. Aspartame is an artificial sweetener that is used in a lot of products, including Diet

July 8, 2023

IVF add-on may be expensive, invasive, and ineffective, study finds

One of the most common add-ons to IVF procedures undertaken in Australia and globally by infertile couples may be a waste of time as well

February 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.